Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 57.00
-0.80 (-1.40%)
Aug 25, 2025, 12:54 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 879.07 million as of August 25, 2025. Its market cap has increased by 1.79% in one year.
Market Cap
879.07M
Enterprise Value
801.98M
Revenue
163.38M
Ranking
n/a
PE Ratio
21.55
Stock Price
57.00
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 879.07M, an increase of 203.53%. That is a compound annual growth rate of 13.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 879.07M | 45.41% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | 839.95M | -12.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.81B |
| Nordhealth AS | 2.90B |
| Photocure ASA | 1.65B |
| ArcticZymes Technologies ASA | 1.50B |
| Vistin Pharma ASA | 1.06B |
| Omda AS | 1.02B |
| Thor Medical ASA | 960.12M |
| Lytix Biopharma AS | 638.93M |